直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Issues and Strategies on Functional Claiming

October 22, 2019

Webinar

Finnegan

Medical Device Manufacturers Association (MDMA)

As part of the Medical Device Manufacturers Association (MDMA) webinar series, Finnegan partners Kathleen Daley and Luke McCammon will present, “Issues and Strategies on Functional Claiming.” The program will discuss the impact of the Federal Circuit’s Williamson v. Citrix decision on functional claiming, including an update on relevant cases, a discussion of issues related to Section 112 and indefiniteness, and claiming strategies for medical devices. For more information, or to register, please visit MDMA’s website.

Tags

indefiniteness (35 USC § 112), claim drafting, functional claiming

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Professionals

Kathleen A. Daley
Partner
Washington, DC
+1 202 408 4098
Email
Luke J. McCammon
Partner
Washington, DC
+1 202 408 4273
Email

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Seminar

3rd AI, IP, & Legal Forum

June 6, 2026

Shangai

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP